Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Mitglied/er, Klinik für Knochenmarktransplantation
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
-
WiSe 2024
-
SoSe 2024
-
WiSe 2023
-
SoSe 2023
-
WiSe 2022
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant : the Azalena-TrialIn: Haematologica / The Hematology Journal, Jg. 108, 2023, Nr. 11, S. 3001 – 3010DOI (Open Access)
-
Optimizing anti-T-lymphocyte globulin dosing to improve long-term outcome after unrelated hematopoietic cell transplantation for hematologic malignanciesIn: American Journal of Transplantation, Jg. 20, 2020, Nr. 3, S. 677 – 688DOI (Open Access)
-
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L) : A randomised, non-inferiority, phase 3 trialIn: The Lancet Haematology, Jg. 7, 2020, Nr. 1, S. e28 – e39
-
Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCRIn: Journal of Clinical Virology, Jg. 99-100, 2018, S. 61 – 66DOI (Open Access)
-
High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemiaIn: British Journal of Haematology, Jg. 180, 2018, Nr. 6, S. 840 – 853
-
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission : retrospective follow-up of an open-label, randomised phase 3 trialIn: The Lancet Haematology, Jg. 5, 2018, Nr. 4, S. e161 – e169
-
CD34+ highly enriched allogeneic stem cell transplantation in a patient with mixed phenotype acute leukemia and Fusarium solani sepsisIn: Annals of Hematology, Jg. 95, 2016, Nr. 1, S. 155 – 156
-
Emergence of linezolid- and vancomycin-resistant Enterococcus faecium in a department for hematologic stem cell transplantationIn: Antimicrobial Resistance and Infection Control, Jg. 5, 2016, 31DOI (Open Access)
-
Encephalitis caused by a novel adenovirus “orphan genome” in an adult allogenic SCT recipientIn: Journal of Clinical Virology, Jg. 82, 2016, S. S11
-
Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-DiseaseIn: Digestive Diseases and Sciences, Jg. 61, 2016, Nr. 7, S. 2019 – 2026
-
Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: A phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)In: Bone Marrow Transplantation, Jg. 50, 2015, Nr. 12, S. 1503 – 1507DOI (Open Access)
-
Human chorionic gonadotropin and indolamine 2,3-dioxygenase in patients with GVHDIn: Bone Marrow Transplantation, Jg. 49, 2014, Nr. 6, S. 800 – 805
-
KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted graftsIn: Annals of Hematology, Jg. 93, 2014, Nr. 9, S. 1579 – 1586
-
Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutationIn: The New England Journal of Medicine, Jg. 371, 2014, Nr. 9, S. 880 – 882
-
Bronchiolitis obliterans after allogeneic hematopoietic SCT : Further insight - New perspectives?In: Bone Marrow Transplantation, Jg. 48, 2013, Nr. 9, S. 1224 – 1229
-
Delayed graft-versus-mast-cell effect on systemic mastocytosis with associated clonal haematological non-mast cell lineage disease after allogeneic transplantationIn: Bone Marrow Transplantation, Jg. 48, 2013, Nr. 5, S. 732 – 733
-
Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia : Comparison with Patients Lacking Donors Who Received AzacitidineIn: Biology of Blood and Marrow Transplantation, Jg. 18, 2012, Nr. 9, S. 1415 – 1421
-
Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. 9, S. 1171 – 1177
-
CMV-replication after allogeneic stem cell transplantation is associated with a GVHD-independent reduced relapse risk in lymphomaIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 156
-
Different Panel of Gene Variants Influence Outcome of Transplant From Sibling Donors Compared to HLA-Identical Unrelated DonorsIn: Blood, Jg. 120, 2012, Nr. 21, S. 4182
-
Different gene variants are associated with outcome of patients transplanted from HLA-identical unrelated donors compared to patients with sibling donorsIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. S165 – S166
-
Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphomaIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. 11, S. 1397 – 1402
-
Dynamic international prognostic scoring system scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosisIn: Haematologica, the hematology journal, Jg. 97, 2012, Nr. 10, S. 1574 – 1581DOI (Open Access)
-
Incidence, mortality and biological characteristics of Bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 51
-
Jian-Jian Luan Award CMV-replication after allogeneic stem cell transplantation is associated with a GvHD-independent reduced relapse risk in lymphoma : evidence for a putative virus-versus-lymphoma effectIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 60
-
Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trialIn: Haematologica, the hematology journal, Jg. 97, 2012, Nr. 9, S. e34 – e35DOI (Open Access)
-
Only gene variants of IL10, IL23R and LCT 13910 influence transplant outcome of patients with HLA-identical unrelated donors as well as patients with sibling donorsIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 127
-
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission : aprospective, open-label randomised phase 3 trialIn: The Lancet Oncology, Jg. 13, 2012, Nr. 10, S. 1035 – 1044
-
Significance of prognostic scores, risk factors and chronic graft-versus-host disease on outcome after allogeneic haematopoietic stem cell transplantation for myelofibrosisIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 433
-
T cells are required for the CMV-induced anti-leukemic effect in patients with acute myeloid leukemia patients after transplantIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 173
-
T-cells but not KIR ligand incompatibilities are required for the CMV-induced anti-leukaemic effect in patients with AML after transplantIn: Bone Marrow Transplantation, Jg. 47, 2012, Nr. Suppl. 1, S. 71
-
Chronic GvHD is the most pivotal factor for improved relapse-free survival in patients with myelofibrosis after myeloablative allogeneic haematopoietic stem cell transplantationIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. Suppl. 1, S. S362 – S362
-
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk : evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patientsIn: Blood, Jg. 118, 2011, Nr. 5, S. 1402 – 1412DOI (Open Access)
-
High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood loadIn: Journal of Clinical Virology, Jg. 52, 2011, Nr. 1, S. 55 – 59
-
Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes : final results of an international prospective phase II trialIn: Haematologica, the hematology journal, Jg. 96, 2011, Nr. 9, S. 1344 – 1350DOI (Open Access)
-
Retrospective analysis of treosulfan-based conditioning in comparison with standard conditioning in patients with myelodysplastic syndromeIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. 4, S. 502 – 509
-
Retrospective evaluation of caspofungin therapy in invasive aspergillosis (RECAM-IA)In: Mycoses, Jg. 54, 2011, Nr. 4, S. e148 – e153
-
Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donorsIn: Bone Marrow Transplantation, Jg. 46, 2011, Nr. 5, S. 702 – 708DOI (Open Access)
-
No influence of gene polymorphism of LCT (C13910T) on transplantation outcomes in acute myeloid leukemia patients who received transplantations from HLA-identical sibling donorsIn: Blood, Jg. 115, 2010, Nr. 17, S. 3644 – 3645
-
Radioimmunotherapy with yttrium-90-ibritumomab tiuxetan as part of a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplantation in patients with advanced non-Hodgkin lymphoma: Results of a phase 2 studyIn: Blood, Jg. 116, 2010, Nr. 10, S. 1795 – 1802
-
Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Patients with Myelodysplastic Syndrome (MDS) : Comparative Analysis of a Randomized Controlled Trial and Real-World DataIn: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 142, 2023, Nr. Supplement 1: Annual Meeting Abstracts (65th ASH Annual Meeting and Exposition, 9-12 Dezember 2023, San Diego), S. 3526 – 3526DOI (Open Access)
-
GVHD and GFRS in patients with AML undergoing allogeneic transplantation with treosulfan- versus busulfan-based conditioning : A subgroup analysis of the randomized phase III MC-FludT.14/L trialIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 57, 2022, Nr. Suppl. 1, S. 35 – 36
-
Graft-versus-host disease (GVHD) and GVHD-free/relapse-free survival (GRFS) in patients with myelodysplastic syndrome (MDS) after treosulfan- versus busulfan-based conditioning and allogeneic hematopoietic cell transplantation (alloHCT)In: Bone Marrow Transplantation. London: Springer Nature, Jg. 57, 2022, Nr. Suppl. 1, S. 37
-
Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions : Final Results of the Prospective Azalena-Trial (NCT02472691)
63rd ASH Annual Meeting and Exposition, 11-14 December 2021, Atlanta,In: Blood. Washington; New York, NY [u.a.]; Philadelphia, Pa.: American Society of Hematology, Jg. 138, 2021, Nr. Supplement 1: 63rd ASH Annual Meeting Abstracts, S. 411 – 412DOI (Open Access) -
CML Relapse after Allogeneic HSCT : Survival, Treatment Efficacy and Prognostic Factors for Outcome
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 275 – 276DOI (Open Access) -
Fertility in Adult Female Allogeneic Stem Cell Recipients
46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) ; 29 August - 1 September, 2020, Virtual Meeting,In: Bone Marrow Transplantation. London: Springer Nature, Jg. 55, 2020, Nr. Suppl. 1, S. 149 – 150DOI (Open Access) -
CML relapse after allogeneic HSCT : survival, treatment efficacy and prognostic factors for outcome
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 218DOI (Open Access) -
Outcome and reconstitution after allogeneic hematopoietic stem cell transplantation in patients with secondary myelofibrosis : a retrospective cohort study
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 11. - 14. Oktober 2019, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 42, 2019, Nr. Supplement 4: Abstracts, S. 283DOI (Open Access) -
Adoptive immunotherapy +/- Ruxolitinib and second allogeneic hematopoietic stem cell transplantation in patients with relapsed Myelofibrosis after allogeneic hematopoietic stem cell transplantation
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 60 – 61DOI (Open Access) -
Impact of anti-Jurkat anti-thymocyte globuline on long-term outcome of Allogeneic matched unrelated donor hematopoietc cell transplantation in hematologic malignancies : A large single-center comparative analysis
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 4, S. 151DOI (Open Access) -
Shift of HIV-Tropism in a HIV-patient with large cell anaplastic T-cell-lymphoma undergoing allogeneic stem cell transplantation from a donor with homozygosity for the CCR5 delta32 mutation
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 10.-14. Oktober 2014, Hamburg,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 5, S. 38 -
Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin's lymphomaIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. 247 – S247
-
Early CMV-replication after allogeneic stem cell transplantation is associated with a dramatically reduced relapse risk in acute myeloid leukaemia patients : evidence for a putative virus-versus-leukaemia effectIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. S56 – S57
-
Improved outcome of transplant in patients with CMLIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. 361 – 362
-
Patients with non-Hodgkin lymphoma receiving treosulfan and fludarabine as reduced-intensity conditioningIn: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 299 – 300
-
Pravastatin after allogeneic haematopoietic stem cell transplantation : better tolerated than expected but without significant influence on chronic graft-versus-host diseaseIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46 1, 2011, Nr. Suppl. 1, S. S111 – S111
-
Results of simultaneous analysis of 48 gene variants reported to have influence on transplant outcomeIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 46, 2011, Nr. Suppl. 1, S. S66 – S67
-
Results of simultaneously performed analysis of 48 gene variants reported to have influence on transplant outcomeIn: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 229
-
Significance of prognostic scores, risk factors and chronic graft-versus-host-disease (cGVHD) on outcome after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosisIn: Onkologie. Basel: Karger, Jg. 34, 2011, Nr. Suppl. 6, S. 206 – 206
-
Improved outcome of transplant in patients with CML
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie. Berlin, 1.–5. Oktober 2010,In: Onkologie. Basel: Karger, Jg. 33, 2010, Nr. Suppl. 6, S. 84 -
Influence of intestinal bacterial decontamination using ciprofloxacin plus metronidazole or moxifloxacin alone on the incidence of acute GvHD and blood stream infections after allogeneic HSCTIn: Bone Marrow Transplantation. London: Springer Nature, Jg. 45, 2010, Nr. Suppl. 2, S. S395
-
Modification of total nodal Irradiation (TNI) as Part of Conditioning prior to allogeneic Stem Cell Transplantation (aSCT) for hematological Diseases using helical Tomotherapy or IMRT based on a retrospective Cohort
27. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, DEGRO 2021, virtuell,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1: Abstracts DEGRO 2021, S. S173DOI (Open Access) -
Modifikation der total nodalen Bestrahlung (TNI) als Teil der Konditionierung vor allogener Stammzelltransplantation (aSZT) bei hämatologischen Erkrankungen mittels helikaler Tomotherapie anhand einer retrospektiven Kohorte
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. Juni - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S105DOI (Open Access)